Clinical Trials in Tennessee

Showing 11221-11240 of 20,239 trials

A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer

NCT03380871

The purpose of this study is to find out if treatment with NEO-PV-01 in combination with pembrolizumab and chemotherapy (pembrolizumab/chemotherapy) is safe and useful for patients with lung cancer. The study also will assess if the NEO-PV-01 vaccine, when given together with pembrolizumab and chemotherapy, can improve your response compared with pembrolizumab and chemotherapy treatment alone. All eligible patients will receive NEO-PV-01 + Adjuvant, pembrolizumab and chemotherapy while on this trial.

Carcinoma, Non-Small-Cell LungLung CancerNonsquamous Nonsmall Cell Neoplasm of Lung

BioNTech US Inc.38 participantsStarted May 2018

Santa Monica, California, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +2 more locations

TERMINATEDPhase 329 miles

Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)

NCT00585312

To test whether celecoxib can be used to prevent colon polyp formation in children with familial adenomatous polyposis (FAP).

Adenomatous Polyposis Coli

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.106 participantsStarted Sep 2006

Chicago, Illinois, United States • Ann Arbor, Michigan, United States • Omaha, Nebraska, United States +39 more locations

A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer

Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)

Find Trials by Condition in Tennessee

MEK162 for Patients With RAS/RAF/MEK Activated Tumors

Celebrex In Acute Gouty Arthritis Study

Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)

Efficacy and Safety of Atacicept in IgA Nephropathy

A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain

A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma

Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents

NAPLS Omega-3 Fatty Acid Versus Placebo Study

Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia

A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders

Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination

Atorvastatin Three Year Pediatric Study

A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer

Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer

Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents

Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients

Safety and Tolerability of PNT001 in Healthy Adults

Hemodialysis Access Surveillance Evaluation Study